Back to Search
Start Over
COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety
- Source :
- Drug Safety
- Publication Year :
- 2021
-
Abstract
- To date, four vaccines have been authorised for emergency use and under conditional approval by the European Medicines Agency to prevent COVID-19: Comirnaty, COVID-19 Vaccine Janssen, Spikevax (previously COVID-19 Vaccine Moderna) and Vaxzevria (previously COVID-19 Vaccine AstraZeneca). Although the benefit–risk profile of these vaccines was proven to be largely favourable in the general population, evidence in special cohorts initially excluded from the pivotal trials, such as pregnant and breastfeeding women, children/adolescents, immunocompromised people and persons with a history of allergy or previous SARS-CoV-2 infection, is still limited. In this narrative review, we critically overview pre- and post-marketing evidence on the potential benefits and risks of marketed COVID-19 vaccines in the above-mentioned special cohorts. In addition, we summarise the recommendations of the scientific societies and regulatory agencies about COVID-19 primary prevention in the same vaccinee categories. Supplementary Information The online version contains supplementary material available at 10.1007/s40264-021-01131-6.
- Subjects :
- Allergy
IMPACT
COVID-19 Vaccine
Breastfeeding
Review Article
Toxicology
Settore MED/42 - Igiene Generale E Applicata
CLINICAL CHARACTERISTICS
Pregnancy
Pharmacology (medical)
Pregnancy Complications, Infectious
Child
OUTCOMES
education.field_of_study
CANCER
Vaccination
Europe
CORONAVIRUS DISEASE 2019, CLINICAL CHARACTERISTICS, CANCER, RECIPIENTS, SEVERITY, OUTCOMES, IMPACT, RATES
Breast Feeding
Child, Preschool
Practice Guidelines as Topic
Female
2019-nCoV Vaccine mRNA-1273
Human
Adult
medicine.medical_specialty
COVID-19 Vaccines
Adolescent
BNT162 Vaccine
COVID-19
ChAdOx1 nCoV-19
Humans
Infant
SARS-CoV-2
Hypersensitivity
Immunocompromised Host
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Population
MEDLINE
CORONAVIRUS DISEASE 2019
medicine
RATES
education
Pharmacology
business.industry
medicine.disease
Vaccine efficacy
RECIPIENTS
SEVERITY
Family medicine
Pregnancy Complications, Infectiou
business
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Drug Safety
- Accession number :
- edsair.doi.dedup.....fcbb1fe9555478fb36e1a7ddd4735ab1